Alcon Announces Launch of Dry Eye Treatment Device
On April 04, 2022, Alcon Inc. announced the launch of their latest dry eye innovation, the Systane® iLux2® Meibomian Gland Dysfunction (MGD) Thermal Pulsation System. It is an all-in-one handheld device equipped with new imaging technology to capture infrared photos and HD video of the meibomian glands which will allow patients to see the need for treatment and visualize their procedure, and experience results in as little as one week.
The Systane iLux2 MGD Thermal Pulsation System would further expand Alcon’s current dry eye treatment offerings and allow practitioners to tailor MGD treatment to the needs of eac...
